Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current lymphoma classification: a step forward for pathologists and clinicians]

D de Jong1, P M Kluin

  • 1Nederlands Kanker Instituut/Antoni van Leeuwenhoek Ziekenhuis, afd. Pathologie, Amsterdam.

Nederlands Tijdschrift Voor Geneeskunde
|August 16, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements.

European journal of nuclear medicine and molecular imaging·2021
Same author

Generation of Fibrodysplasia ossificans progressiva and control integration free iPSC lines from periodontal ligament fibroblasts.

Stem cell research·2019
Same author

A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas.

PloS one·2019
Same author

Corrigendum to "Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression Profile." <i>Neoplasia</i> 2009, Feb;11(2):167-176.

Neoplasia (New York, N.Y.)·2019
Same author

Magnetic field compatible circuit quantum electrodynamics with graphene Josephson junctions.

Nature communications·2018
Same author

Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.

Annals of hematology·2017

The Revised European-American Lymphoma (REAL) Classification integrates pathology and clinical data for Non-Hodgkin lymphomas. This system aids communication and the development of targeted therapies for specific lymphoma entities.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Context:

  • Non-Hodgkin lymphomas present diverse clinical and pathological features.
  • Effective communication among specialists requires a standardized classification system.

Purpose:

  • To introduce the Revised European-American Lymphoma (REAL) Classification.
  • To establish a unified system integrating diverse data for lymphoma classification.

Summary:

  • The REAL Classification (1994) merges morphological, immunohistochemical, molecular, and cytogenetic data.
  • It distinguishes distinct clinical-pathological entities with characteristic spectra, evolution, and presentations.
  • This approach facilitates a deeper understanding of lymphoma heterogeneity.

Impact:

Related Experiment Videos

  • The REAL Classification improves communication among pathologists, clinicians, and researchers.
  • It enables the development of targeted therapies for specific lymphoma subtypes.
  • Represents a significant advancement in the field of hemato-oncology.